Salmonellosis

Salmonellosis is a bacterial infectious disease caused by various serotypes of Salmonella enterica, a Gram-negative, facultative anaerobic, motile bacillus belonging to the family Enterobacteriaceae. In veterinary medicine, salmonellosis manifests as a spectrum of clinical syndromes ranging from acute gastroenteritis with diarrhea, vomiting, and fever to severe systemic illness with septicemia, endotoxemia, and multi-organ failure. The disease can also present as a subclinical carrier state, where animals shed the organism intermittently without overt clinical signs, posing a significant zoonotic and nosocomial risk. Salmonella species are classified into two species: S. enterica (with six subspecies) and S. bongori. Clinically relevant serovars in companion animals include S. enterica subsp. enterica serovars Typhimurium, Enteritidis, Newport, and Heidelberg, among others. The disease is of particular importance in young, geriatric, or immunocompromised animals, and in crowded environments such as shelters, kennels, and veterinary hospitals. Salmonellosis is a zoonotic disease, with transmission occurring via the fecal-oral route, contaminated food, water, or fomites. The clinical presentation can be highly variable, ranging from asymptomatic shedding to peracute fatal septicemia, making accurate diagnosis and prompt therapeutic intervention critical.

The primary causative agents of salmonellosis are bacteria of the genus Salmonella, specifically Salmonella enterica subspecies enterica. Over 2,500 serovars have been identified, but the most commonly isolated serovars in dogs and cats include Typhimurium, Enteritidis, Newport, Heidelberg, and Dublin. These are Gram-negative, non-spore-forming, facultatively anaerobic bacilli that are motile via peritrichous flagella. Virulence factors include endotoxin (lipopolysaccharide, LPS) in the outer membrane, which triggers a potent inflammatory response; flagellin, which activates Toll-like receptor 5 (TLR5); and various adhesins and invasins (e.g., type III secretion systems) that facilitate intestinal epithelial invasion and survival within macrophages. Salmonella can also form biofilms, enhancing environmental persistence. Transmission occurs primarily via the fecal-oral route, through ingestion of contaminated food (especially raw meat, eggs, unpasteurized milk), water, or contact with contaminated surfaces. In veterinary hospitals, nosocomial transmission can occur via fomites, hands, or equipment. The organism can survive for extended periods in the environment, particularly in moist, organic material. In healthy adult animals, the gastric acid barrier and normal intestinal microbiota provide some protection, but factors such as antacid therapy, altered gut flora, or immunosuppression can lower the infectious dose. Salmonella is a facultative intracellular pathogen, allowing it to evade immune clearance and establish persistent infection in the reticuloendothelial system, leading to a carrier state.

Salmonellosis affects a wide range of animal species, including dogs, cats, horses, cattle, pigs, poultry, and wildlife. In companion animals, the prevalence of Salmonella shedding is generally low in healthy pets (1-3%) but can be significantly higher in certain populations, such as shelter animals, racing greyhounds, and animals fed raw meat diets. A study in the United States found that 8% of dogs fed raw diets shed Salmonella, compared to 0% in dogs fed commercial diets. Age is a significant risk factor, with puppies and kittens under 6 months of age being more susceptible to clinical disease due to immature immune systems and lower gastric acidity. Breed predispositions are not well-documented, but stress, overcrowding, and poor sanitation increase the risk. Geographic distribution is worldwide, with higher incidence in tropical and subtropical regions. Seasonality is not pronounced, but outbreaks may occur in summer months due to increased bacterial proliferation in warm environments. In veterinary hospitals, nosocomial outbreaks have been reported, particularly in equine and small animal intensive care units. The zoonotic potential is significant, with transmission from pets to humans documented, especially in immunocompromised individuals. The incidence of clinical salmonellosis in dogs and cats is relatively low compared to food animals, but the disease can be severe and potentially fatal, especially in young or debilitated animals.

The pathophysiology of salmonellosis begins with ingestion of Salmonella organisms. After surviving the gastric acid barrier, the bacteria adhere to and invade the intestinal epithelium, primarily in the distal small intestine and colon. The invasion is mediated by type III secretion systems (T3SS-1 and T3SS-2) that inject effector proteins into host cells, inducing membrane ruffling and macropinocytosis. Once inside the host cell, Salmonella resides within a modified phagosome called the Salmonella-containing vacuole (SCV), where it can replicate. The bacteria can also be taken up by M cells in Peyer's patches and transported to underlying lymphoid tissue, leading to systemic dissemination via the lymphatic system and bloodstream. The host inflammatory response is triggered by recognition of bacterial components (LPS, flagellin) by pattern recognition receptors (TLR4, TLR5) on intestinal epithelial cells and macrophages, leading to the release of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8) and chemokines. This results in neutrophil infiltration, mucosal damage, and increased intestinal permeability, causing diarrhea, which may be watery, mucoid, or hemorrhagic. In severe cases, endotoxemia occurs due to massive release of LPS, leading to systemic inflammatory response syndrome (SIRS), septic shock, disseminated intravascular coagulation (DIC), and multi-organ failure. The bacteria can also invade the bloodstream directly, causing bacteremia and seeding of organs such as the liver, spleen, lungs, and joints. Chronic infection can lead to a carrier state, where Salmonella persists in the gallbladder, mesenteric lymph nodes, or intestinal mucosa, with intermittent shedding. The severity of disease depends on the virulence of the serovar, the infectious dose, and the host's immune status.

Several intrinsic and extrinsic factors predispose animals to salmonellosis. Intrinsic factors include age (young animals have immature immune systems and lower gastric acidity), immunosuppression (due to concurrent viral infections such as canine distemper or feline leukemia virus, or drug-induced immunosuppression), and genetic susceptibility (certain breeds may have altered immune responses, though specific genetic markers are not well-defined). Extrinsic factors include dietary practices, particularly the feeding of raw meat or undercooked eggs, which are common sources of Salmonella. Stressful conditions such as overcrowding, transportation, hospitalization, or surgery can increase susceptibility by altering the gut microbiota and reducing gastric acid secretion. Concurrent gastrointestinal diseases, such as inflammatory bowel disease or parasitic infections, may disrupt the mucosal barrier. The use of antacids or H2 blockers reduces gastric acidity, lowering the infectious dose required. Antibiotic therapy can disrupt the normal intestinal flora, allowing Salmonella to colonize more easily. Environmental factors such as poor sanitation, contaminated water sources, and exposure to infected animals or their feces increase the risk of exposure. In veterinary hospitals, nosocomial transmission is a significant concern, especially in intensive care units where immunocompromised patients are housed.

The clinical signs of salmonellosis in dogs and cats can be highly variable, ranging from subclinical infection to peracute fatal septicemia. The incubation period is typically 12-72 hours after ingestion. The most common clinical presentation is acute gastroenteritis, characterized by vomiting, diarrhea (which may be watery, mucoid, or hemorrhagic), fever, anorexia, lethargy, and abdominal pain. Diarrhea may be profuse and lead to dehydration, electrolyte imbalances, and metabolic acidosis. In peracute cases, animals may present with shock, hypothermia, collapse, and death within hours, often without preceding gastrointestinal signs. Subacute and chronic cases may show intermittent diarrhea, weight loss, and poor condition. Systemic signs of bacteremia and endotoxemia include pyrexia (or hypothermia in severe cases), tachycardia, tachypnea, pale mucous membranes, prolonged capillary refill time, and signs of DIC such as petechiae or ecchymoses. In some animals, localized infections may occur, leading to pneumonia, polyarthritis, osteomyelitis, meningitis, or abortion in pregnant females. Neurological signs may be observed if meningitis or encephalitis develops. Cats may also present with a more chronic syndrome characterized by fever, anorexia, and weight loss, sometimes without diarrhea. Asymptomatic carriers are common and may shed Salmonella intermittently, especially during periods of stress.

The differential diagnoses for salmonellosis include other causes of acute gastroenteritis and systemic infection. Key differentials include: 1) Canine parvovirus (CPV) infection: causes severe hemorrhagic diarrhea, vomiting, and leukopenia, especially in puppies; diagnosis via fecal antigen test or PCR. 2) Canine distemper: presents with respiratory, gastrointestinal, and neurological signs; diagnosis via PCR or serology. 3) Feline panleukopenia (feline parvovirus): similar to CPV in cats, with severe leukopenia and gastroenteritis; diagnosis via fecal antigen test or PCR. 4) Campylobacteriosis: caused by Campylobacter jejuni, leading to diarrhea and fever; diagnosis via fecal culture or PCR. 5) Clostridial enterotoxicosis (Clostridium perfringens): causes acute diarrhea, sometimes hemorrhagic; diagnosis via fecal toxin assay or PCR. 6) Giardiasis: protozoal infection causing chronic diarrhea; diagnosis via fecal antigen test or microscopy. 7) Inflammatory bowel disease (IBD): chronic gastrointestinal signs without infectious etiology; diagnosis via intestinal biopsy. 8) Dietary indiscretion or toxin exposure: can cause acute gastroenteritis; history and response to symptomatic treatment. 9) Hemorrhagic gastroenteritis (HGE): acute onset of bloody diarrhea and vomiting, often in small breed dogs; diagnosis by exclusion, with hemoconcentration. 10) Sepsis from other bacterial sources (e.g., E. coli): may present similarly; blood cultures and other diagnostic tests are needed. Definitive diagnosis of salmonellosis requires isolation of Salmonella from feces, blood, or other tissues, or detection via PCR.

The diagnostic approach to suspected salmonellosis should be systematic and thorough. Step 1: Obtain a detailed history, including diet (especially raw meat), environment, recent stress, and vaccination status. Step 2: Perform a complete physical examination, with attention to hydration status, body temperature, abdominal palpation, and signs of systemic illness. Step 3: Initial laboratory tests include a complete blood count (CBC), serum biochemistry profile, and urinalysis. These may reveal leukopenia or leukocytosis, hemoconcentration, electrolyte imbalances, and evidence of organ dysfunction. Step 4: Fecal examination for parasitic ova and protozoa, and fecal antigen tests for parvovirus (in dogs) or panleukopenia (in cats) to rule out common viral causes. Step 5: If salmonellosis is suspected, submit fecal samples for bacterial culture and sensitivity. Multiple samples (at least 3) collected over several days may increase the yield, as shedding can be intermittent. Enrichment media (e.g., selenite broth) and selective media (e.g., MacConkey agar, XLD agar) are used. Step 6: In cases of systemic illness, blood cultures should be obtained before antibiotic administration. Step 7: Molecular diagnostics, such as PCR, can detect Salmonella DNA in feces or blood and provide rapid results. Step 8: Imaging (abdominal radiographs or ultrasound) may be indicated to rule out other causes of gastrointestinal signs, such as foreign bodies or intussusception. Step 9: In severe or chronic cases, additional tests such as coagulation profile, blood gas analysis, and assessment of organ function (e.g., liver enzymes, renal parameters) are warranted. Step 10: If the animal is a suspected carrier, repeated fecal cultures or PCR may be needed to confirm the carrier state. The diagnostic algorithm should be adapted based on the clinical presentation and available resources.

Laboratory findings in salmonellosis are variable and depend on the severity and stage of the disease. Hematology: In acute cases, the CBC may show leukopenia due to neutropenia, particularly in severe infections, as neutrophils are consumed in the inflammatory response. Alternatively, a leukocytosis with a left shift may be present in less severe cases. Anemia may occur due to blood loss from hemorrhagic diarrhea or hemolysis. Thrombocytopenia may be present in cases of DIC. Serum biochemistry: Dehydration may lead to prerenal azotemia (elevated BUN and creatinine). Electrolyte imbalances are common, including hyponatremia, hypokalemia, and metabolic acidosis due to bicarbonate loss in diarrhea. Liver enzymes (ALT, AST) may be elevated if there is hepatic involvement or endotoxemia. Hypoalbuminemia may occur due to protein-losing enteropathy. Blood gas analysis may reveal metabolic acidosis with a compensatory respiratory alkalosis. Urinalysis: May show concentrated urine (high USG) due to dehydration, and proteinuria or casts if there is renal involvement. Specific biomarkers: Inflammatory markers such as C-reactive protein (CRP) may be elevated. Procalcitonin has been studied as a marker of bacterial sepsis in dogs. Serology: Antibody detection is not commonly used for diagnosis due to poor sensitivity and specificity. PCR: Fecal PCR for Salmonella is highly sensitive and specific and can provide rapid results. Blood cultures are positive in bacteremic animals. Coagulation profile: Prolonged PT and aPTT, elevated FDPs and D-dimers, and decreased antithrombin III may indicate DIC. Fecal cytology: May show increased neutrophils and red blood cells, but is not diagnostic. Overall, laboratory findings are supportive but not pathognomonic; definitive diagnosis requires isolation or molecular detection of Salmonella.

Imaging findings in salmonellosis are generally non-specific but can help rule out other causes of gastrointestinal signs. Abdominal radiographs may show gas-filled loops of intestine, fluid-filled bowel, and sometimes evidence of ileus. In cases of severe enteritis, the intestinal wall may appear thickened. However, radiographs are not diagnostic for salmonellosis. Abdominal ultrasonography may reveal thickened intestinal walls, increased echogenicity of the mucosa, and hyperechoic mesentery due to inflammation. In cases of septic peritonitis, free abdominal fluid may be seen. Thoracic radiographs may be indicated if pneumonia is suspected, showing an interstitial or alveolar pattern. In cases of septic arthritis, radiographs of affected joints may show soft tissue swelling and joint effusion. Advanced imaging such as CT or MRI is rarely needed but may be used to evaluate for abscesses or other focal infections. Endoscopy can be performed to visualize the intestinal mucosa and obtain biopsies, which may show inflammatory changes but are not specific for Salmonella. Imaging is primarily used to rule out other conditions and to assess for complications such as intussusception, perforation, or peritonitis.

Cytological and histopathological findings in salmonellosis are characterized by acute inflammation and tissue damage. Fecal cytology may show increased numbers of neutrophils, red blood cells, and macrophages, but this is non-specific. Fine needle aspirates of enlarged lymph nodes or other organs may reveal pyogranulomatous inflammation with intracellular bacteria. Histopathology of the intestine typically shows severe necrotizing enteritis with mucosal ulceration, crypt abscesses, and infiltration of neutrophils and macrophages. The lamina propria is edematous and hyperemic. In systemic cases, the liver may show multifocal necrosis and infiltration of inflammatory cells, and the spleen may have lymphoid depletion and necrosis. In chronic cases, there may be granulomatous inflammation with epithelioid macrophages. Special stains such as Gram stain can demonstrate Gram-negative bacilli within tissues. Immunohistochemistry or fluorescence in situ hybridization (FISH) can be used to specifically identify Salmonella in tissue sections. In cases of septicemia, bacteria may be seen in blood vessels or within macrophages in various organs. Histopathology is not commonly performed for diagnosis but may be useful in post-mortem examination or in chronic cases where other diagnostics have failed.

The treatment of salmonellosis in dogs and cats depends on the severity of clinical signs. In mild cases with only diarrhea and no systemic signs, supportive care may be sufficient, and antibiotics are generally not recommended, as they may prolong the carrier state. However, in cases with fever, hemorrhagic diarrhea, or signs of systemic infection, antimicrobial therapy is indicated. The choice of antibiotic should ideally be based on culture and sensitivity, but empirical therapy may be initiated while awaiting results. Commonly used antibiotics include fluoroquinolones (e.g., enrofloxacin at 5-10 mg/kg PO or IV q24h, or ciprofloxacin at 10-20 mg/kg PO q12h), third-generation cephalosporins (e.g., ceftriaxone at 25-50 mg/kg IV or IM q12h, or cefovecin at 8 mg/kg SC q14 days), or amoxicillin-clavulanate (12.5-25 mg/kg PO q12h). In severe cases, combination therapy with a fluoroquinolone and a beta-lactam may be used. Treatment duration is typically 5-7 days, but may be extended in immunocompromised animals. Supportive care is crucial: intravenous fluid therapy with balanced crystalloids (e.g., Lactated Ringer's solution) at rates to correct dehydration and maintain perfusion (e.g., 60-100 ml/kg/day in dogs, 40-60 ml/kg/day in cats, adjusted based on losses). Electrolyte and acid-base abnormalities should be corrected. Anti-emetics such as maropitant (1 mg/kg IV or SC q24h) or metoclopramide (0.2-0.5 mg/kg IV or SC q8h) may be used for vomiting. Gastroprotectants such as famotidine (0.5-1 mg/kg IV or PO q12h) or omeprazole (0.5-1 mg/kg PO q24h) may be considered. Probiotics may help restore normal gut flora. Nutritional support is important; a highly digestible, low-fat diet may be offered in small, frequent meals. In cases of septic shock, aggressive fluid resuscitation, vasopressors (e.g., norepinephrine CRI), and possibly plasma transfusions may be needed. Surgical intervention is rarely indicated, except for complications such as intestinal perforation or abscessation. Hospitalization and isolation are recommended to prevent nosocomial spread.

The prognosis for salmonellosis in dogs and cats is generally good for mild cases with appropriate supportive care, with a mortality rate of less than 10%. However, the prognosis is guarded to poor in cases of severe septicemia, endotoxemia, or DIC, with mortality rates reported as high as 50% or more. Factors associated with a poorer prognosis include young age (puppies and kittens), old age, immunosuppression, delayed treatment, presence of concurrent disease, and the development of multi-organ failure. Negative prognostic indicators include persistent leukopenia, severe metabolic acidosis, refractory hypotension, and evidence of DIC. Animals that recover may become chronic carriers and shed Salmonella intermittently, which can be a source of infection for other animals and humans. The carrier state may persist for weeks to months, and some animals may shed for life. Recurrence of clinical disease is uncommon but possible, especially if the animal becomes stressed or immunocompromised. With prompt and aggressive treatment, many animals recover fully, but long-term follow-up is recommended to monitor for carrier status.

Follow-up care for animals with salmonellosis is essential to ensure complete recovery and to minimize the risk of zoonotic transmission. After initial treatment, animals should be re-evaluated within 7-14 days to assess clinical improvement and to repeat fecal cultures or PCR to determine if they are still shedding Salmonella. It is recommended to obtain at least three consecutive negative fecal cultures (collected 1-2 weeks apart) before considering the animal free of infection. In animals that remain positive, repeat cultures should be performed monthly until negative. Owners should be educated about the zoonotic risk and proper hygiene practices, including hand washing after handling the animal or its feces, and disinfecting contaminated areas with appropriate agents (e.g., dilute bleach solution). Animals that are carriers should be isolated from immunocompromised individuals and other animals, especially in households with young children or elderly people. Dietary recommendations may include avoiding raw meat diets, as these are a common source of Salmonella. Long-term monitoring may include periodic fecal cultures in high-risk animals, such as those in shelters or breeding facilities. In animals with chronic or recurrent infections, further diagnostic workup may be needed to identify underlying immunosuppression or other predisposing factors. Regular veterinary check-ups are recommended to monitor overall health and to address any complications.

Clinical Pearls: 1) Always consider salmonellosis in any animal with acute gastroenteritis, especially if there is a history of raw meat feeding or exposure to high-risk environments. 2) In severe cases, blood cultures should be obtained before starting antibiotics to increase the chance of identifying the causative organism. 3) Antibiotics are not recommended for mild, uncomplicated cases of salmonellosis, as they may prolong the carrier state. 4) Use of probiotics may help restore normal gut flora and reduce the duration of diarrhea. 5) In hospitalized animals, strict isolation and barrier nursing are essential to prevent nosocomial outbreaks. 6) Fecal culture is the gold standard for diagnosis, but PCR is faster and can be used as a screening test. 7) Always inform owners about the zoonotic potential of salmonellosis, especially in households with immunocompromised members. Clinical Pitfalls: 1) Do not rely solely on fecal cytology or antigen tests, as they are not specific for Salmonella. 2) Avoid using antibiotics that are not effective against Salmonella, such as first-generation cephalosporins or macrolides, as they may not penetrate the intracellular environment. 3) Do not discharge animals with diarrhea without confirming they are not shedding Salmonella, as this poses a public health risk. 4) Do not overlook the possibility of concurrent infections, such as parvovirus, which may complicate the clinical picture. 5) In cases of septic shock, do not delay aggressive fluid therapy and vasopressor support, as early intervention improves outcomes. 6) Do not forget to monitor for DIC in severe cases, as it is a common complication and requires prompt treatment.

Antimicrobial therapy: For systemic salmonellosis, fluoroquinolones are often the first choice. Enrofloxacin: 5-10 mg/kg PO or IV q24h for 5-7 days (dogs); 5 mg/kg PO or IV q24h (cats, but caution with high doses due to risk of retinal toxicity). Ciprofloxacin: 10-20 mg/kg PO q12h (dogs). Third-generation cephalosporins: Ceftriaxone: 25-50 mg/kg IV or IM q12h (dogs and cats). Cefovecin: 8 mg/kg SC q14 days (dogs and cats). Amoxicillin-clavulanate: 12.5-25 mg/kg PO q12h (dogs and cats). Trimethoprim-sulfamethoxazole: 15-30 mg/kg PO q12h (dogs and cats). Chloramphenicol: 50 mg/kg PO q8h (dogs) or 25-50 mg/kg PO q12h (cats) – use with caution due to potential bone marrow suppression. Supportive care: Fluid therapy: Lactated Ringer's solution or Normosol-R at 60-100 ml/kg/day (dogs) and 40-60 ml/kg/day (cats), adjusted based on hydration status and ongoing losses. For shock, administer boluses of 20-30 ml/kg (dogs) or 10-20 ml/kg (cats) over 15-30 minutes, repeated as needed. Anti-emetics: Maropitant: 1 mg/kg SC or IV q24h (dogs and cats). Metoclopramide: 0.2-0.5 mg/kg IV or SC q8h, or as a CRI at 1-2 mg/kg/day (dogs and cats). Gastroprotectants: Famotidine: 0.5-1 mg/kg IV or PO q12h (dogs and cats). Omeprazole: 0.5-1 mg/kg PO q24h (dogs and cats). Probiotics: e.g., FortiFlora (Purina) or Proviable (Nutramax) at label doses. Nutritional support: Highly digestible diet (e.g., Hill's i/d or Royal Canin Gastrointestinal) in small, frequent meals. In cases of DIC, treatment may include fresh frozen plasma (10-15 ml/kg IV) and heparin (e.g., unfractionated heparin at 200-300 IU/kg SC q8h). For septic shock, vasopressors such as norepinephrine (0.05-0.5 mcg/kg/min CRI) or vasopressin (0.5-2 mU/kg/min CRI) may be used. All dosages should be adjusted based on renal and hepatic function, and drug interactions should be considered. Antibiotic therapy should be based on culture and sensitivity whenever possible.

Evidence-based literature on salmonellosis in dogs and cats is limited but provides important insights. A study by Leonard et al. (2011) found that feeding raw meat diets to dogs significantly increased the risk of Salmonella shedding, with 8% of raw-fed dogs shedding the organism compared to 0% of dogs fed commercial diets. Another study by Finley et al. (2007) reported that Salmonella was present in 20% of raw pet food samples, highlighting the risk of dietary transmission. In terms of clinical management, a retrospective study by Marks et al. (2011) evaluated 50 cases of salmonellosis in dogs and cats, finding that the most common clinical signs were diarrhea (80%), vomiting (60%), and fever (50%). The study reported a mortality rate of 10% overall, but higher in cases with septicemia. Antibiotic treatment was associated with prolonged shedding, supporting the recommendation to avoid antibiotics in mild cases. A consensus statement from the International Society for Companion Animal Infectious Diseases (ISCAID) on the use of antimicrobials in dogs and cats with gastrointestinal signs (Lappin et al., 2017) recommends that antimicrobial therapy be reserved for cases with fever, hemorrhagic diarrhea, or evidence of systemic infection. The statement also emphasizes the importance of culture and sensitivity testing. Regarding zoonotic transmission, a case-control study by Sato et al. (2000) identified contact with dogs and cats as a risk factor for human salmonellosis, particularly in children. These findings underscore the importance of public health education and hygiene measures. Overall, the literature supports a conservative approach to antibiotic use, aggressive supportive care, and strict hygiene protocols to prevent transmission.